June 1, 2019: Dr. Venkatesan Sundaresan, professor at the University of California, Davis, joins NAPIGEN as scientific advisor.
May 23, 2019: NAPIGEN is chosen for one of the finalists to present at the Startup Stadium, BIO 2019 World Congress, held on July 8-11 in Des Moines, Iowa.
May 9, 2019: The patent application “Organelle genome modification using polynucleotide guided endonuclease” is published in US (US 2019/0136249 A1)
May 2, 2019: NAPIGEN is chosen for one of the finalists to present at the Startup Stadium, BIO 2019 International Convention, held on June 3-6 in Philadelphia.
April 22, 2019: NAPIGEN wins “Pitch to Partnering” program of Delaware Bio.
March 18, 2019: Presentation at the World Ag-Tech Pitch Day in San Francisco, CA.
March 7, 2019: Breakout Labs grants the fund to NAPIGEN, Inc.
February 19, 2019: Radicle Growth chose NAPIGEN, Inc. as one of the eight finalists from over 150 international entries for the Radicle Challenge competition
October 19, 2018: Dr. Peter Langridge, professor at the University of Adelaide, Australia, International Science Coordinator at the Wheat Initiative, joins NAPIGEN as scientific advisor.
June 26-28, 2018: Presentation and showcase at THRIVE Demo Day in Forbes Ag Tech Summit in Salinas, CA.
April 1, 2018: Dr. Thomas Fox, professor at the Department of Molecular Biology and Genetics,
Cornell University, joins NAPIGEN as scientific advisor.
March 14, 2018: THRIVE SVG selects NAPIGEN as one of the nine cohorts out of 167 companies
worldwide for their Accelerator program.
February, 2018: NAPIGEN closes the Research Service agreement with Kaneka Corp.